
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lack of T-Cell Receptor–Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Claus‐Detlev Klemke, Dirk Brenner, Eva-Maria Weiβ, et al.
Cancer Research (2009) Vol. 69, Iss. 10, pp. 4175-4183
Open Access | Times Cited: 57
Claus‐Detlev Klemke, Dirk Brenner, Eva-Maria Weiβ, et al.
Cancer Research (2009) Vol. 69, Iss. 10, pp. 4175-4183
Open Access | Times Cited: 57
Showing 26-50 of 57 citing articles:
Dysregulated expression of SKP2 and its role in hematological malignancies
Michał Kuliński, Iman W. Achkar, Mohammad Haris, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 59, Iss. 5, pp. 1051-1063
Closed Access | Times Cited: 16
Michał Kuliński, Iman W. Achkar, Mohammad Haris, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 59, Iss. 5, pp. 1051-1063
Closed Access | Times Cited: 16
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma
Sara Peru, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 12, pp. 3243-3252.e10
Closed Access | Times Cited: 8
Sara Peru, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 12, pp. 3243-3252.e10
Closed Access | Times Cited: 8
Loss of nuclear pro–IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma
Clara Curiel‐Lewandrowski, H Yamasaki, Chuan Ping, et al.
Journal of Clinical Investigation (2011) Vol. 121, Iss. 12, pp. 4838-4849
Open Access | Times Cited: 15
Clara Curiel‐Lewandrowski, H Yamasaki, Chuan Ping, et al.
Journal of Clinical Investigation (2011) Vol. 121, Iss. 12, pp. 4838-4849
Open Access | Times Cited: 15
Aberrant expression of BCL 11B in mycosis fungoides and its potential role in interferon‐induced apoptosis
Xiaoguang Gu, Yang Wang, Gaolei Zhang, et al.
The Journal of Dermatology (2013) Vol. 40, Iss. 8, pp. 596-605
Closed Access | Times Cited: 14
Xiaoguang Gu, Yang Wang, Gaolei Zhang, et al.
The Journal of Dermatology (2013) Vol. 40, Iss. 8, pp. 596-605
Closed Access | Times Cited: 14
Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study
Jianqiang Wu, Gary S. Wood
JAMA Dermatology (2018) Vol. 154, Iss. 10, pp. 1191-1191
Open Access | Times Cited: 13
Jianqiang Wu, Gary S. Wood
JAMA Dermatology (2018) Vol. 154, Iss. 10, pp. 1191-1191
Open Access | Times Cited: 13
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis
Sharad S. Singhal, Ravi Salgia, Nisan Verma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 1, pp. 188337-188337
Open Access | Times Cited: 12
Sharad S. Singhal, Ravi Salgia, Nisan Verma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 1, pp. 188337-188337
Open Access | Times Cited: 12
ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma
Mengzhou Cao, Pan Lai, Xiangjun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Mengzhou Cao, Pan Lai, Xiangjun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma
Shan Xiong, Fengjie Liu, Jingru Sun, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 12, pp. 2778-2788.e9
Closed Access | Times Cited: 1
Shan Xiong, Fengjie Liu, Jingru Sun, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 12, pp. 2778-2788.e9
Closed Access | Times Cited: 1
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients
Susanne Melchers, M. Roemer, John D. Albrecht, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access | Times Cited: 1
Susanne Melchers, M. Roemer, John D. Albrecht, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access | Times Cited: 1
The Tumor Microenvironment as a Therapeutic Target in Cutaneous T Cell Lymphoma
Louis Boafo Kwantwi, Steven T. Rosen, Christiane Querfeld
Cancers (2024) Vol. 16, Iss. 19, pp. 3368-3368
Open Access | Times Cited: 1
Louis Boafo Kwantwi, Steven T. Rosen, Christiane Querfeld
Cancers (2024) Vol. 16, Iss. 19, pp. 3368-3368
Open Access | Times Cited: 1
Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer
Shinichirou Izawa, Kousaku Mimura, Mitsuaki Watanabe, et al.
Cancer Immunology Immunotherapy (2012) Vol. 62, Iss. 1, pp. 161-170
Open Access | Times Cited: 12
Shinichirou Izawa, Kousaku Mimura, Mitsuaki Watanabe, et al.
Cancer Immunology Immunotherapy (2012) Vol. 62, Iss. 1, pp. 161-170
Open Access | Times Cited: 12
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma
Salvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 10, pp. 2304-2314
Open Access | Times Cited: 12
Salvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 10, pp. 2304-2314
Open Access | Times Cited: 12
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, M. Bagot, Paul J. Neeson, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 691-697
Closed Access | Times Cited: 12
Carrie Van Der Weyden, M. Bagot, Paul J. Neeson, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 691-697
Closed Access | Times Cited: 12
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome
X. Martínez, Cosimo Di Raimondo, Farah Abdulla, et al.
Best Practice & Research Clinical Haematology (2019) Vol. 32, Iss. 3, pp. 239-252
Open Access | Times Cited: 11
X. Martínez, Cosimo Di Raimondo, Farah Abdulla, et al.
Best Practice & Research Clinical Haematology (2019) Vol. 32, Iss. 3, pp. 239-252
Open Access | Times Cited: 11
Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma
Changrim Lee, Santosh Peddi, Caleb F. Anderson, et al.
Biomaterials (2020) Vol. 262, pp. 120338-120338
Open Access | Times Cited: 11
Changrim Lee, Santosh Peddi, Caleb F. Anderson, et al.
Biomaterials (2020) Vol. 262, pp. 120338-120338
Open Access | Times Cited: 11
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
Elisabetta Caprini, Antonella Bresin, Cristina Cristofoletti, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 12
Open Access | Times Cited: 11
Elisabetta Caprini, Antonella Bresin, Cristina Cristofoletti, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 12
Open Access | Times Cited: 11
Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments
Tara Bloom, Timothy M. Kuzel, Christiane Querfeld, et al.
Current Treatment Options in Oncology (2012) Vol. 13, Iss. 1, pp. 102-121
Closed Access | Times Cited: 9
Tara Bloom, Timothy M. Kuzel, Christiane Querfeld, et al.
Current Treatment Options in Oncology (2012) Vol. 13, Iss. 1, pp. 102-121
Closed Access | Times Cited: 9
Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes
A. Moerman, Daniel A. Acheampong, Amanda G. Brooks, et al.
Oncotarget (2019) Vol. 10, Iss. 49, pp. 5052-5069
Open Access | Times Cited: 7
A. Moerman, Daniel A. Acheampong, Amanda G. Brooks, et al.
Oncotarget (2019) Vol. 10, Iss. 49, pp. 5052-5069
Open Access | Times Cited: 7
IKK antagonizes activation-induced cell death of CD4+ T cells in aged mice via inhibition of JNK activation
Hongbin Deng, Genxiang Mao, Jingpu Zhang, et al.
Molecular Immunology (2010) Vol. 48, Iss. 1-3, pp. 287-293
Closed Access | Times Cited: 5
Hongbin Deng, Genxiang Mao, Jingpu Zhang, et al.
Molecular Immunology (2010) Vol. 48, Iss. 1-3, pp. 287-293
Closed Access | Times Cited: 5
c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases
Katrin A. Salva, Margo J. Reeder, Rita Lloyd, et al.
American Journal of Dermatopathology (2016) Vol. 39, Iss. 10, pp. 731-737
Open Access | Times Cited: 3
Katrin A. Salva, Margo J. Reeder, Rita Lloyd, et al.
American Journal of Dermatopathology (2016) Vol. 39, Iss. 10, pp. 731-737
Open Access | Times Cited: 3
Dimethyl fumarate and extracorporeal photopheresis combination-therapy synergize in inducing specific cell death and long-term remission in cutaneous T cell lymphoma
Özge Çiçek Şener, Susanne Melchers, Luisa Tengler, et al.
Leukemia (2024)
Open Access
Özge Çiçek Şener, Susanne Melchers, Luisa Tengler, et al.
Leukemia (2024)
Open Access
What Can Psoriasis Teach Us About the Genetic Basis of Cutaneous T-Cell Lymphoma?
James T. Elder
Clinical Lymphoma Myeloma & Leukemia (2010) Vol. 10, pp. S70-S73
Closed Access | Times Cited: 2
James T. Elder
Clinical Lymphoma Myeloma & Leukemia (2010) Vol. 10, pp. S70-S73
Closed Access | Times Cited: 2
SATB1: Key Regulator of T Cell Development and Differentiation
P. Kamalvishnu, Mithila Burute, Sanjeev Galande
InTech eBooks (2012)
Open Access | Times Cited: 1
P. Kamalvishnu, Mithila Burute, Sanjeev Galande
InTech eBooks (2012)
Open Access | Times Cited: 1
FAS-670A>G gene polymorphism and the risk of allograft rejection after organ transplantation: a systematic review and meta-analysis
Mohammad Masoud Eslami, Ramazan Rezaei, Sara Abdollahi, et al.
Blood Research (2021) Vol. 56, Iss. 1, pp. 17-25
Open Access | Times Cited: 1
Mohammad Masoud Eslami, Ramazan Rezaei, Sara Abdollahi, et al.
Blood Research (2021) Vol. 56, Iss. 1, pp. 17-25
Open Access | Times Cited: 1
Silencing Autocrine Death: A Ubiquitin Ligase that Blocks Activation-Induced Cell Death in Cutaneous T-Cell Lymphoma
Claus‐Detlev Klemke, Maria Feoktistova, Martin Leverkus
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 3, pp. 662-665
Open Access
Claus‐Detlev Klemke, Maria Feoktistova, Martin Leverkus
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 3, pp. 662-665
Open Access